{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:49:26Z","timestamp":1761562166250},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.japh.2016.08.009","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T06:01:38Z","timestamp":1478152898000},"page":"67-71.e1","source":"Crossref","is-referenced-by-count":4,"title":["Pharmaceutical assistance programs to support smoking cessation medication access"],"prefix":"10.1016","volume":"57","author":[{"given":"Angie","family":"Leon-Salas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie J.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimber P.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niaman","family":"Nazir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward F.","family":"Ellerbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa I.","family":"Shireman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"260","key":"10.1016\/j.japh.2016.08.009_bib1","first-page":"69","article-title":"Summary health statistics for U.S. adults: National Health Interview Survey, 2012. National Center for Health Statistics","volume":"10","author":"Blackwell","year":"2014","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.japh.2016.08.009_bib2","series-title":"Treating tobacco use and dependence. Clinical practice guideline 2008 update","author":"Fiore","year":"2008"},{"issue":"44","key":"10.1016\/j.japh.2016.08.009_bib3","first-page":"1513","article-title":"Quitting smoking among adults\u2014United States, 2001-2010","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.japh.2016.08.009_bib4","series-title":"Income, poverty, and health insurance coverage in the United States: 2010","author":"DeNavas-Walt","year":"2011"},{"issue":"2","key":"10.1016\/j.japh.2016.08.009_bib5","first-page":"116","article-title":"Understanding smoking cessation in rural communities","volume":"24","author":"Hutcheson","year":"2008","journal-title":"J\u00a0Rural Health"},{"issue":"21 Suppl.\u00a07","key":"10.1016\/j.japh.2016.08.009_bib6","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2146\/ajhp060464","article-title":"Patient assistance programs and patient advocacy foundations: alternatives for obtaining prescription medications when insurance fails","volume":"63","author":"Johnson","year":"2006","journal-title":"Am J Health Syst Pharm"},{"issue":"7","key":"10.1016\/j.japh.2016.08.009_bib7","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/archinte.162.7.780","article-title":"Pharmaceutical manufacturer assistance programs","volume":"162","author":"Chisholm","year":"2002","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.japh.2016.08.009_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1353\/hpu.2011.0003","article-title":"What is the evidence for pharmaceutical patient assistance programs? A systematic review","volume":"22","author":"Felder","year":"2011","journal-title":"J\u00a0Health Care Poor Underserved"},{"issue":"3","key":"10.1016\/j.japh.2016.08.009_bib9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1377\/hlthaff.28.3.827","article-title":"Drug company-sponsored patient assistance programs: a viable safety net?","volume":"28","author":"Choudhry","year":"2009","journal-title":"Health Aff Proj Hope"},{"issue":"2","key":"10.1016\/j.japh.2016.08.009_bib10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cct.2014.04.008","article-title":"Design and participant characteristics of a randomized-controlled trial of telemedicine for smoking cessation among rural smokers","volume":"38","author":"Mussulman","year":"2014","journal-title":"Contemp Clin Trials"},{"issue":"5","key":"10.1016\/j.japh.2016.08.009_bib11","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.2196\/jmir.3975","article-title":"Comparative and cost effectiveness of telemedicine versus telephone counseling for smoking cessation","volume":"17","author":"Richter","year":"2015","journal-title":"J\u00a0Med Internet Res"},{"key":"10.1016\/j.japh.2016.08.009_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/ntr\/ntq215","article-title":"Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC four country survey","volume":"13","author":"Barmford","year":"2011","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.japh.2016.08.009_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/ntr\/nts084","article-title":"An internet survey of use, opinions and preferences for SCM: nicotine, varenicline, and bupropion","volume":"15","author":"Etter","year":"2013","journal-title":"Nicotin Tob Res"},{"issue":"7","key":"10.1016\/j.japh.2016.08.009_bib14","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/ajhp\/62.7.726","article-title":"Patient-assistance programs: assessment of and use by safety-net clinics","volume":"62","author":"Duke","year":"2005","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.japh.2016.08.009_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.sapharm.2013.04.001","article-title":"Predictors of $4 generic prescription drug discount programs use in the low-income population","volume":"10","author":"Omojasola","year":"2014","journal-title":"Res Soc Adm Pharm"},{"issue":"2","key":"10.1016\/j.japh.2016.08.009_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.amjopharm.2009.04.003","article-title":"Awareness of pharmaceutical cost-assistance programs among inner-city seniors","volume":"7","author":"Federman","year":"2009","journal-title":"Am J Geriatr Pharmacother"},{"issue":"2","key":"10.1016\/j.japh.2016.08.009_bib17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/SMJ.0b013e31818bbe5e","article-title":"Pharmaceuticals companies' medication assistance programs: potentially useful but too burdensome to use?","volume":"102","author":"Pisu","year":"2009","journal-title":"South Med J"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319116307828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319116307828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T18:47:51Z","timestamp":1692557271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319116307828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1544319116307828"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2016.08.009","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}